Biogen Inc. Price Today
Biogen Inc.
BIIB
Healthcare
$29.79B
💰
Market Cap
25.7
💸
Price to Earnings
$8.0
🎉
EPS
+78
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
20 |
Strong Buy |
10 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
BIIB Price Forecast Target
204.9 👉 500.0 +144%
BIIB EPS Forecast
8.0 👉 17.6 +121%
Financials
Profit Margin
12 %
Revenue Growth
-6.2 %
Dividend
$ 0
Held Percent
0.7% - Insiders
93.0% - Institutions
6.3% - Public
Major Fund Holders
-
💰 Primecap Management Company $3.3B
-
💰 Vanguard Group Inc $3.0B
-
💰 Blackrock Inc. $2.9B
-
💰 State Street Corporation $1.4B
-
💰 T. Rowe Price Investment Management, Inc. $1.1B
Stock Ideas
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
George Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the world…
Bill Ackman Portfolio
Bill Ackman, a renowned investor, has established himself as a long-term value investor with a keen eye for short-term price fluctuations. His expertise lies in special situations investments, and his Pershing Square portfolio reflects a highly conc…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.📮FAQ
Some Frequently Asked Questions.
The Biogen Inc. industry is Drug Manufacturers - General
The Biogen Inc. sector is Healthcare
The Biogen Inc. forecasted predicted Price to Earnings PE ratio is 11.6
The Biogen Inc. Price to Earnings PE ratio is 25.7
The Market Capitalization of Biogen Inc. is $29.79B
There are total of 144811334 float shares with 93.0% held by Institutions and 0.7% held by insiders
The MBiogen Inc. forecasted Earnings per Share EPS is $17.6
The Biogen Inc. Earnings per Share EPS is 8.0
The Biogen Inc. company has $0 gross profits with 12 profit margins
The Biogen Inc. Earnings Growth is -0.549% with -0.546% quarterly earnings growth
The Biogen Inc. Revenue is $9835599872 with -0.062 revenue growth
The price target for Biogen Inc. stock is $500.0 for the high target and $215.0 for the low target
The consensus analyst recommendations for Biogen Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Biogen Inc. is Buy, with the following breakdown:
- Buy: 20
- Strong Buy: 10
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of Biogen Inc. is -0.0
The dividend of Biogen Inc. is $0
The dividend yield of Biogen Inc. is 0%
The biggest institutional and mutual fund holders of Biogen Inc. stock are
- Primecap Management Company
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
The Biogen Inc. ESG Score is 78, with the following breakdown:
- E: 0.42
- S: 14.46
- G: 7.37